Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Burjis S. who wrote (43478)	6/7/1999 10:35:00 PM
From: kha vu	Read Replies (1) of 120523

SEPR versus CELG: I am a long term holding of SEPR. But there is a new player in the field of Improved Chemical Entity: CELG. <<<Warren, New Jersey-based Celgene's strategy is similar to that pioneered by Sepracor (SEPR: news, msgs), which develops and brings to market improved chemical entities that are new, patented forms of existing pharmaceuticals. The products can offer reduced side effects, improved safety, new uses, and improved dosage forms over traditional compounds. Attention deficit disorder is a problem related to brain development that causes hyperactivity, impulsive behavior and attention problems, according to InteliHealth, the online information service of the Johns Hopkins University Medical system. Celgene estimates that about 1 million children in the U.S. have the disorder. That number may be underreported, the company said. >>>>>>>>>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next